4
Changes in Ownership
SELLAS Life Sciences Group, Inc. Filed Acc 0001250853-14-000039
Director sold 250,000 shares at $5.28 ($1,320,000)
- Director acquired 250,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nisi Rudolph Director | 2014-01-29 | Option exercise | +50,000 | $2.31 | $115,500 | 53,500 | D |
| Nisi Rudolph Director | 2014-01-29 | Option exercise | +100,000 | $1.18 | $118,000 | 153,500 | D |
| Nisi Rudolph Director | 2014-01-29 | Option exercise | +50,000 | $0.72 | $36,000 | 203,500 | D |
| Nisi Rudolph Director | 2014-01-29 | Option exercise | +50,000 | $1.71 | $85,500 | 253,500 | D |
| Nisi Rudolph Director | 2014-01-29 | Sale | −250,000 | $5.28 | $1,320,000 | 3,500 | D |
| Derivatives | |||||||
| Nisi Rudolph Director | 2014-01-29 | Option exercise · Stock Option (right to buy) | −50,000 | 0 | D | ||
| Nisi Rudolph Director | 2014-01-29 | Option exercise · Stock Option (right to buy) | −100,000 | 0 | D | ||
| Nisi Rudolph Director | 2014-01-29 | Option exercise · Stock Option (right to buy) | −50,000 | 0 | D | ||
| Nisi Rudolph Director | 2014-01-29 | Option exercise · Stock Option (right to buy) | −50,000 | 0 | D | ||
| Open-market sales · 250,000 sh · avg $5.28 · $1,320,000 | |||||||
Loading xslF345X03/primary_doc.xml…